Watson Pharma (WPI) Forms Global Integration Manangement Office to Support Actavis Purchase

Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that it has created a Global Integration Management Office, reporting directly to Paul M. Bisaro, President and Chief Executive Officer, and focusing on planning and implementing the integration of Actavis, following the announcement of Watson's intention to acquire the Zug, Switzerland-based company. Marc Lehnen, Ph.D., has been designated to lead the Global Integration Management Office in the newly created position of Senior Vice President, Global Integration Management. Dr. Lehnen will join Watson effective July 1, 2012, and report to Mr. Bisaro.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Real and RE/MAX Holdings receive court approval for merger
• Nuvectis Pharma (NVCT) files $200M mixed shelf
• Lazard Global Total Return fund declares $0.1534 monthly distribution